You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CUE Sale Disclosure
Meluzio Michael Vincent · SEC Form 4 · Filed Oct 14, 2026
Sale
Calculated transaction value
$32.09K
Meluzio Michael Vincent VP, Prin. Accounting Officer
CUE
Cue Biopharma
CUE
Transaction date
Oct 12, 2026
Public filing date
Oct 14, 2026
Filing lag
Filed 2 days later
CUE daily price context
Close on/before transaction
$24.61
Oct 12, 2026
First close after public filing
$18.67
Oct 15, 2026
Return after filing · so far
-0.05%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,144 shares @ $28.05
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002138368-26-000009
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$32.09K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cue Biopharma, Inc. CUE Current | Sale | Oct 12, 2026 | $32.09K |